From the article you linked:
"ESR Australia is paying a speculated price of over $45 million for a Coolaroo industrial investment with immediate development upside.
The 8.2 hectare property, 2-50 Glenelg Street, was offloaded by Palla Pharma, which outlaid $8.145m in 2014."
An outlay of $8.145 then booking a gain of around $20 million. Looks like this company is better at property investing.
- Forums
- ASX - By Stock
- PAL
- Ann: Sale and Leaseback of Coolaroo Site
Ann: Sale and Leaseback of Coolaroo Site, page-16
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)